New courses on pharmacokinetic and pharmacodynamic studies
Zenosis, the leading provider of eLearning for the medicinal products industry, has announced the release of two new courses:
- PKPD01: An Introduction to Pharmacokinetics and Pharmacodynamics in Drug Development and Registration
- PKPD02: Conducting Pharmacokinetic and Pharmacodynamic Studies
Pharmacokinetic (PK) and pharmacodynamic (PD) studies provide a bridge between science and medicine in the development of a drug. PKPD01 describes the role of in-vivo PK and PD studies in a drug development programme, sets out the uses to which the findings can be put, and discusses their implications for clinical development and application for marketing approval.
PKPD02 extends the learner’s understanding of pharmacokinetic and pharmacodynamic studies from the basics described in PKPD01. It provides detail on a variety of aspects of such studies: design, sampling, data analysis, research in special populations, and bioequivalence testing.
These courses will benefit pharmacologists, nonclinical researchers, clinical researchers, regulatory affairs staff, and others who contribute to drug development and registration.